317 related articles for article (PubMed ID: 33844027)
21. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.
Zgorzynska E; Dziedzic B; Walczewska A
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501
[TBL] [Abstract][Full Text] [Related]
22. USP10 inhibits the dopamine-induced reactive oxygen species-dependent apoptosis of neuronal cells by stimulating the antioxidant Nrf2 activity.
Sango J; Kakihana T; Takahashi M; Katsuragi Y; Anisimov S; Komatsu M; Fujii M
J Biol Chem; 2022 Jan; 298(1):101448. PubMed ID: 34838592
[TBL] [Abstract][Full Text] [Related]
23. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
[TBL] [Abstract][Full Text] [Related]
24. Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson's disease.
Choi JW; Kim S; Yoo JS; Kim HJ; Kim HJ; Kim BE; Lee EH; Lee YS; Park JH; Park KD
Eur J Med Chem; 2021 Feb; 212():113103. PubMed ID: 33387904
[TBL] [Abstract][Full Text] [Related]
25. Sestrin2 overexpression alleviates hydrogen peroxide-induced apoptosis and oxidative stress in retinal ganglion cells by enhancing Nrf2 activation via Keap1 downregulation.
Fan Y; Xing Y; Xiong L; Wang J
Chem Biol Interact; 2020 Jun; 324():109086. PubMed ID: 32275923
[TBL] [Abstract][Full Text] [Related]
26. Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy.
Adelusi TI; Du L; Hao M; Zhou X; Xuan Q; Apu C; Sun Y; Lu Q; Yin X
Biomed Pharmacother; 2020 Mar; 123():109732. PubMed ID: 31945695
[TBL] [Abstract][Full Text] [Related]
27. A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models.
Lee JA; Son HJ; Park KD; Han SH; Shin N; Kim JH; Kim HR; Kim DJ; Hwang O
Neurotox Res; 2015 Nov; 28(4):332-45. PubMed ID: 26233727
[TBL] [Abstract][Full Text] [Related]
28. Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage.
Lim JH; Kim KM; Kim SW; Hwang O; Choi HJ
Pharmacol Res; 2008 May; 57(5):325-31. PubMed ID: 18455424
[TBL] [Abstract][Full Text] [Related]
29. Chlorhexidine as a Keap1-Nrf2 inhibitor: a new target for an old drug for Parkinson's disease therapy.
Unni S; Deshmukh P; Krishnappa G; Bharath MMS; Padmanabhan B
J Biomol Struct Dyn; 2023; 41(12):5367-5381. PubMed ID: 35713597
[TBL] [Abstract][Full Text] [Related]
30. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.
Sharma V; Kaur A; Singh TG
Biomed Pharmacother; 2020 Sep; 129():110373. PubMed ID: 32603894
[TBL] [Abstract][Full Text] [Related]
31. MDA-7/IL-24 inhibits Nrf2-mediated antioxidant response through activation of p38 pathway and inhibition of ERK pathway involved in cancer cell apoptosis.
Tian H; Zhang D; Gao Z; Li H; Zhang B; Zhang Q; Li L; Cheng Q; Pei D; Zheng J
Cancer Gene Ther; 2014 Oct; 21(10):416-26. PubMed ID: 25236495
[TBL] [Abstract][Full Text] [Related]
32. [Effect and mechanism of moxibustion on oxidative stress injury in rats with Parkinson's disease by activating Nrf2/ARE pathway].
Liu XL; Lu J; Tian Y; Zhang GY; Zhao CP; Wang TT; Li XR; Zhu ML
Zhongguo Zhen Jiu; 2020 Aug; 40(8):857-62. PubMed ID: 32869595
[TBL] [Abstract][Full Text] [Related]
33. Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity.
Williamson TP; Johnson DA; Johnson JA
Neurotoxicology; 2012 Jun; 33(3):272-9. PubMed ID: 22342405
[TBL] [Abstract][Full Text] [Related]
34. Activation of kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2/antioxidant response element pathway by curcumin enhances the anti-oxidative capacity of corneal endothelial cells.
Guo SP; Chang HC; Lu LS; Liu DZ; Wang TJ
Biomed Pharmacother; 2021 Sep; 141():111834. PubMed ID: 34153850
[TBL] [Abstract][Full Text] [Related]
35. Novel diterpenoid-type activators of the Keap1/Nrf2/ARE signaling pathway and their regulation of redox homeostasis.
Li AL; Shen T; Wang T; Zhou MX; Wang B; Song JT; Zhang PL; Wang XL; Ren DM; Lou HX; Wang XN
Free Radic Biol Med; 2019 Sep; 141():21-33. PubMed ID: 31167117
[TBL] [Abstract][Full Text] [Related]
36. The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
Lu MC; Ji JA; Jiang ZY; You QD
Med Res Rev; 2016 Sep; 36(5):924-63. PubMed ID: 27192495
[TBL] [Abstract][Full Text] [Related]
37. Possible activation of NRF2 by Vitamin E/Curcumin against altered thyroid hormone induced oxidative stress via NFĸB/AKT/mTOR/KEAP1 signalling in rat heart.
Mishra P; Paital B; Jena S; Swain SS; Kumar S; Yadav MK; Chainy GBN; Samanta L
Sci Rep; 2019 May; 9(1):7408. PubMed ID: 31092832
[TBL] [Abstract][Full Text] [Related]
38. Mild ozonisation activates antioxidant cell response by the Keap1/Nrf2 dependent pathway.
Galiè M; Costanzo M; Nodari A; Boschi F; Calderan L; Mannucci S; Covi V; Tabaracci G; Malatesta M
Free Radic Biol Med; 2018 Aug; 124():114-121. PubMed ID: 29864481
[TBL] [Abstract][Full Text] [Related]
39. BRUP-1, an intracellular bilirubin modulator, exerts neuroprotective activity in a cellular Parkinson's disease model.
Kataura T; Saiki S; Ishikawa KI; Akamatsu W; Sasazawa Y; Hattori N; Imoto M
J Neurochem; 2020 Oct; 155(1):81-97. PubMed ID: 32128811
[TBL] [Abstract][Full Text] [Related]
40. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
Nezu M; Suzuki N; Yamamoto M
Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
